The bedside arrival of blockbuster medicines like ibrutinib and osimertinib changed the narrative on oncogene-driven cancers. How? Cysteine. Reporting in 2024, Takahashi et al. comprehensively map the covalently targetable cysteines across 416 cancer models, defining biological and structural principles of target tractability. Welcome to DrugMap.
Hello,
Thanks for this very impressive study and resource. When I browse the data available through the UI, I do not see similar results in the files available through the Data Downloads.
e.g. TP53 KB05
https://drugmap.net/index.php?gene=TP53&probe=KB05
Are the web UI stats different from what is provided in those files? Is there an approach I can use to get to the same summaries through the data downloads?
Hello, Thanks for this very impressive study and resource. When I browse the data available through the UI, I do not see similar results in the files available through the Data Downloads. e.g. TP53 KB05 https://drugmap.net/index.php?gene=TP53&probe=KB05
vs the data download for KB05 https://drugmap.net/download.php?file=KB05.v.3.xlsx
Are the web UI stats different from what is provided in those files? Is there an approach I can use to get to the same summaries through the data downloads?
Best regards, Matt